The lifetime risk of developing bipolar II disorder is 5-7%, yet
the condition is often poorly detected. Mood elevation states are
less extreme than in bipolar I disorder although the depressive
episodes are usually severe. When correctly treated, the outcome is
positive, but bipolar II is often poorly managed, resulting in a
high suicide rate. This is the only academic and clinical
management review focused entirely on bipolar II, scrutinizing
history, epidemiology, burden and neurobiology and including an
extensive clinical debate by international experts about effective
management strategies. Now in its third edition, this book features
new chapters on the limitations to clinical treatment trials and
perinatal management nuances. In a completely new section,
international experts offer their personal responses and
distinctive wisdom to key management issues and allow the reader to
observe a variety of opinions.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!